MYC and acute lymphoblastic leukemia: Recent studies have shown that deletions of TAD boundaries in T‐ALL patients result in the fusion of MYC‐TAD with adjacent TADs, leading to abnormal interactions between the enhancer BDME/BENC and the MYC promoter within the fused TAD.